SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-21-011421
Filing Date
2021-11-22
Accepted
2021-11-22 17:15:13
Documents
79
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT admp-10q_063021.htm   iXBRL 10-Q 2049316
2 SETTLEMENT AGREEMENT ex10-1.htm EX-10.1 43244
3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 9420
4 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 9334
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 3684
6 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 3755
  Complete submission text file 0001387131-21-011421.txt   8679588

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE admp-20210630.xsd EX-101.SCH 48916
8 XBRL CALCULATION FILE admp-20210630_cal.xml EX-101.CAL 77105
9 XBRL DEFINITION FILE admp-20210630_def.xml EX-101.DEF 219176
10 XBRL LABEL FILE admp-20210630_lab.xml EX-101.LAB 410454
11 XBRL PRESENTATION FILE admp-20210630_pre.xml EX-101.PRE 334756
12 EXTRACTED XBRL INSTANCE DOCUMENT admp-10q_063021_htm.xml XML 1715830
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36242 | Film No.: 211433587
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences